Nanopublication: RAOV_EcuL6

Full identifier: http://purl.org/np/RAOV_EcuL6oHKOUamSF9Mz2linK3j5d4G8WXSU4IgCIj0

Raw formats: TriG(html,txt), JSON-LD(txt), N-Quads(txt), XML(txt)

Checking for updates...

 RAOV_EcuL6 comment approve/disapprove edit as derived nanopublication create new with same template

This is a local identifier minted within the nanopublication. http://purl.org/np/RAOV_EcuL6...#association This association http://www.w3.org/2000/01/rdf-schema#label has label (this is a literal) "clindamycin is a lincosamide antibacterial indicated for the treatment of the following 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 limitation of use 1 9 to reduce the development of drug resistant bacteria and maintain the effectiveness of clindamycin in 9 sodium chloride injection and other antibacterial drugs clindamycin in 9 sodium chloride injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria 1 1 clindamycin in 9 sodium chloride injection is indicated for the treatment of serious infections caused by susceptible anaerobic bacteria see indications and usage 1 3 1 7 clindamycin in 9 sodium chloride injection is indicated for the treatment of serious infections due to susceptible strains of streptococci pneumococci and staphylococci its use should be reserved for penicillin allergic patients or other patients for whom in the judgment of the physician a penicillin is inappropriate because of the risk of antibacterial associated pseudomembranous colitis see boxed warning bacteriologic studies should be performed to determine the causative organisms and their susceptibility to clindamycin indicated surgical procedures should be performed in conjunction with antibacterial therapy clindamycin in 9 sodium chloride injection is indicated in the treatment of serious lower respiratory tract infections including pneumonia empyema and lung abscess caused by susceptible strains of anaerobes streptococcus pneumoniae e faecalis staphylococcus aureus clindamycin in 9 sodium chloride injection is indicated in the treatment of serious skin and skin structure infections caused by susceptible strains of streptococcus pyogenes staphylococcus aureus clindamycin in 9 sodium chloride injection is indicated in the treatment of serious gynecological infections including endometritis nongonococcal tubo ovarian abscess pelvic cellulitis and postsurgical vaginal cuff infection caused by susceptible anaerobes clindamycin in 9 sodium chloride injection is indicated in the treatment of serious intra abdominal infections including peritonitis and intra abdominal abscess caused by susceptible anaerobic organisms clindamycin in 9 sodium chloride injection is indicated in the treatment of serious septicemia caused by susceptible strains of staphylococcus aureus enterococcus faecalis clindamycin in 9 sodium chloride injection is indicated in the treatment of serious bone and joint infections including acute hematogenous osteomyelitis caused by susceptible strains of staphylococcus aureus since clindamycin does not diffuse adequately into the cerebrospinal fluid clindamycin in 9 sodium chloride injection should not be used in the treatment of meningitis see clinical pharmacology 12 3 to reduce the development of drug resistant bacteria and maintain the effectiveness of clindamycin in 9 sodium chloride injection and other antibacterial drugs clindamycin in 9 sodium chloride injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria when culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy" .
This is the identifier for this whole nanopublication. http://purl.org/np/RAOV_EcuL6... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal) "2021-06-12T15:16:41.107+02:00" .
This is the identifier for this whole nanopublication. http://purl.org/np/RAOV_EcuL6... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAManV5GZI... RAManV5GZI .
This is the identifier for this whole nanopublication. http://purl.org/np/RAOV_EcuL6... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW... RANwQa4ICW .
This is the identifier for this whole nanopublication. http://purl.org/np/RAOV_EcuL6... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC... RAA2MfqdBC .
This is a local identifier minted within the nanopublication. http://purl.org/np/RAOV_EcuL6...#sig sig http://purl.org/nanopub/x/hasSignatureTarget has as target This is the identifier for this whole nanopublication. http://purl.org/np/RAOV_EcuL6... this nanopublication .
This is a local identifier minted within the nanopublication. http://purl.org/np/RAOV_EcuL6...#sig sig http://purl.org/nanopub/x/hasAlgorithm has the algorithm (this is a literal) "RSA" .

Leoni Bücken, 12 Jun 2021, 13:16:41 UTC

show references